<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03875703</url>
  </required_header>
  <id_info>
    <org_study_id>K170603J</org_study_id>
    <nct_id>NCT03875703</nct_id>
  </id_info>
  <brief_title>Post-Vaccination Biological Collection</brief_title>
  <acronym>BioCol-VIR</acronym>
  <official_title>Biological Collection for Studying Vaccine-induced Immune Responses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction: Vaccination is a powerful weapon in the fight against infectious diseases,&#xD;
      which has led to dramatic reduction in mortality and complications from some diseases. In&#xD;
      this respect, vaccination is a real worldwide public health challenge (WHO). Thus, vaccine&#xD;
      research benefits from an exponential development of knowledge in immunology and&#xD;
      biotechnology. In particular, the advent of recent tools (&quot;omics&quot;, new cytometric assays) and&#xD;
      the description of new categories of immune cells (Tfh, BReg...) have revolutionized the&#xD;
      characterization of immune responses, particularly post-vaccination. To study of the immune&#xD;
      response following vaccination remains essential in order to define the immunological&#xD;
      correlates to vaccine protection. This response also varies according to parameters related&#xD;
      to the vaccine (type, adjuvant, dose, regimen…) and to the vaccinated host (genetics, age,&#xD;
      morbidity, treatment …). Analyzing with new generation immune assays, new data on&#xD;
      immunological responses post-vaccination from a clinical cohort is therefore essential to&#xD;
      better define these correlates.&#xD;
&#xD;
      Objective: To develop new vaccines (HIV, emerging infectious diseases) the investigators use&#xD;
      a &quot;System vaccinology&quot; method to decipher the mechanisms of immune responses set up against&#xD;
      vaccines currently being developed or marketed, specifically in specific populations&#xD;
      (patients with primary immune deficiency, sickle cell patients, solid organ transplanted&#xD;
      patients, COPD).&#xD;
&#xD;
      Method: Description of the genetic, molecular and cellular mechanisms of the immune response&#xD;
      to vaccines recommended for adults, in particular influenza and pneumococcal vaccines, but&#xD;
      also other mandatory vaccines (MMR,...) or vaccine for travelers (yellow fever, ...) as part&#xD;
      of routine care in different population categories (healthy subjects, HIV+ subjects, COPD&#xD;
      patients, …), using qualitative and quantitative immunological assays: transcriptional&#xD;
      analysis of the dynamic innate immune response, analysis of the lymphocytes B &amp; T responses&#xD;
      (phenotype, repertoire analysis, functional analysis including T reg and TFH populations,&#xD;
      antibody response), genetic analysis in the context of primary immune deficiencies)&#xD;
      Conclusion: The data generated will allow the best possible analysis of vaccine responses&#xD;
      according to vaccines and vaccinated populations, providing important information for the&#xD;
      research developed within the department.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2019</start_date>
  <completion_date type="Anticipated">February 1, 2030</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2030</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in transcriptional analysis, analysis of the innate immune response after vaccination</measure>
    <time_frame>Hour 24 after vaccination</time_frame>
    <description>Transcriptomic analysis performed from whole blood samples</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>B cell immune response</measure>
    <time_frame>at Day 0, Day 7, Day 14 and Month 1 after vaccination</time_frame>
    <description>(phenotype, analysis of the repertoire B, functional analysis, antibody response, plasmablastic response)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>T cell immune response</measure>
    <time_frame>at Day 0, Day 7, Day 14 and Month 1 after vaccination</time_frame>
    <description>(phenotype, T repertoire analysis, functional analysis, especially of the Treg and TFH populations)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specific antibody response to the used vaccines at M1</measure>
    <time_frame>at Month 1</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Vaccination</condition>
  <condition>Immune Response</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood &amp; serum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients who receive a vaccination in the department of Immunology and Infectious&#xD;
        Diseases of the Henri Mondor University Hospital (Créteil, France).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years old&#xD;
&#xD;
          -  Informed and consented&#xD;
&#xD;
          -  Need to be vaccinated for routine care&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Person under guardianship or safeguards&#xD;
&#xD;
          -  Pregnant or breastfeeding woman&#xD;
&#xD;
          -  No affiliation to a health insurance scheme&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laetitia Gregoire</last_name>
    <role>Study Chair</role>
    <affiliation>APHP URC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sébastien Gallien, PHD</last_name>
    <phone>01 49 81 44 33</phone>
    <phone_ext>+33</phone_ext>
    <email>sebastien.gallien@aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pr Gallien</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastien Gallien, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>January 18, 2019</study_first_submitted>
  <study_first_submitted_qc>March 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2019</study_first_posted>
  <last_update_submitted>December 11, 2020</last_update_submitted>
  <last_update_submitted_qc>December 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Biological Collection</keyword>
  <keyword>Vaccination</keyword>
  <keyword>Active Immune Response</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

